Medikaloka Hermina (HEAL.IJ): 2Q26 Earnings: Below; Resilient Top Line, Softer Margins
Medikaloka Hermina (HEAL IJ)2Q26 Earnings: Below; Resilient Top Line, Softer Margins. 2Q26 earnings missed estimates despite resilient revenue...
95 Views
Medikaloka Hermina (HEAL.IJ) - Solid 3Q25 Earnings Recovery...
We maintain Buy rating with a slightly higher DCF-based TP of Rp1,950 (prev. Rp1,850); the LT margin expansion story remains intact.
243 Views
Healthcare: 3Q25 Preview: Hospitals Soft Vs. Consensus, Pharma Stable
Hospitals: 3Q25 patient vol. improved yoy from a low 3Q24 base; 9M25 in line with our (77%) but may miss cons (68%), HEAL & SILO drags.
218 Views
Healthcare: 2Q25 Preview: Defensive Profile Intact Despite Growth Normalization
We also expect Pharma’s 1H25 earnings to be in-line with 54% run-rate, with KLBF’s intact cost-efficiency, potential quarterly rebound in SIDO.
284 Views
Healthcare: Updates on KRIS and Co-Payment Regulation (OVERWEIGHT)
MOH postponed KRIS until Dec25 due to equipment and space hurdles. Meanwhile, iDRG and new BPJS tariff are in finalization stage.
252 Views